RI S2535 | 2018 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 5-0)
Status: Introduced on March 1 2018 - 25% progression, died in committee
Action: 2018-03-27 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 1 2018 - 25% progression, died in committee
Action: 2018-03-27 - Committee recommended measure be held for further study
Pending: Senate Health and Human Services Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative and to pay an annual fee for each name listed with the department of business regulation.
Title
Prescription Drug Sales - Representative Disclosure Act
Sponsors
| Sen. Joshua Miller [D] | Sen. Gayle Goldin [D] | Sen. Jeanine Calkin [D] | Sen. Adam Satchell [D] |
| Sen. Leonidas Raptakis [D] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-03-27 | Senate | Committee recommended measure be held for further study |
| 2018-03-12 | Senate | Scheduled for hearing and/or consideration (03/27/2018) |
| 2018-03-12 | Senate | Meeting postponed (03/13/2018) |
| 2018-03-09 | Senate | Scheduled for hearing and/or consideration |
| 2018-03-08 | Senate | Meeting postponed (03/08/2018) |
| 2018-03-02 | Senate | Scheduled for hearing and/or consideration |
| 2018-03-01 | Senate | Introduced, referred to Senate Health and Human Services |
Subjects
Rhode Island State Sources
| Type | Source |
|---|---|
| Summary | https://status.rilegislature.gov/ |
| Text | https://webserver.rilegislature.gov/BillText18/SenateText18/S2535.pdf |
